Friday, 19 April, 2024
Kathmandu, Oct. 16: The government has issued permit for the import, sales and distribution of Remdesivir, an anti-viral drug used in treatment of COVID-19, in Nepal.
The Department of Drug Administration has issued permit to three companies-two Nepalis and one Indian- for the same, informed Dr Samir Kumar Adhikari, Deputy Spokesperson at the Ministry of Health and Population.
Yeti Pharmacem Distributors Pvt Ltd, Lalitpur and Synergy Overseas Pvt Ltd, Kathmandu are the Nepali companies and Hetero Labs Limited is the Indian one.
In the context of no any antidote against COVID-19 developed as of now, the Remdesivir is used in Nepal for the research purpose.
Do not make expressions casting dout on election: EC
14 Apr, 2022
CM Bhatta says may New Year 2079 BS inspire positive thinking
14 Apr, 2022
Three new cases, 44 recoveries in 24 hours
14 Apr, 2022
689 climbers of 84 teams so far acquire permits for climbing various peaks this spring season
14 Apr, 2022
How the rising cost of living crisis is impacting Nepal
14 Apr, 2022
US military confirms an interstellar meteor collided with Earth
14 Apr, 2022
Valneva Covid vaccine approved for use in UK
14 Apr, 2022
Chair Prachanda highlights need of unity among Maoist, Communist forces
14 Apr, 2022
Ranbir Kapoor and Alia Bhatt: Bollywood toasts star couple on wedding
14 Apr, 2022
President Bhandari confers decorations (Photo Feature)
14 Apr, 2022
